Source: IndiaMedToday

Novartis: Novartis India N-Exit plan in Disarray: Market Rollercoaster Derails $200 M Stake Sale

Stock swings and valuation woes are learnt to have stalled Swiss pharma giant Novartis's plans to sell its 70.68 per cent stake in Novartis India The Swiss pharmaceutical titan Novartis' much-anticipated exit from its Indian arm has hit turbulent waters, with market volatility and valuation concerns throwing a wrench in the $200 million stake sale, [...]

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
Vasant Narasimhan's photo - CEO of Novartis

CEO

Vasant Narasimhan

CEO Approval Rating

88/100

Read more